In our study of asthma patients, serum mTOR levels in the asthma attack group were significantly higher than those in the remission, pneumonia, and control groups, and the last three groups showed no significant differences, which suggested that the mTOR signaling pathway was activated during asthma and inhibited when asthma was alleviated. The gene discussed is MTOR; the disease is asthma.